- Home
- XTNT vs ASRT Comparison
XTNT vs ASRT Comparison
Compare XTNT & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XTNT
- ASRT
- Stock Information
- Founded
- XTNT N/A
- ASRT 1995
- Country
- XTNT United States
- ASRT United States
- Employees
- XTNT N/A
- ASRT N/A
- Industry
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- ASRT Biotechnology: Pharmaceutical Preparations
- Sector
- XTNT Health Care
- ASRT Health Care
- Exchange
- XTNT Nasdaq
- ASRT Nasdaq
- Market Cap
- XTNT 60.9M
- ASRT 65.7M
- IPO Year
- XTNT N/A
- ASRT 1997
- Fundamental
- Price
- XTNT $0.45
- ASRT $0.60
- Analyst Decision
- XTNT Strong Buy
- ASRT Strong Buy
- Analyst Count
- XTNT 1
- ASRT 3
- Target Price
- XTNT $3.00
- ASRT $3.08
- AVG Volume (30 Days)
- XTNT 66.0K
- ASRT 432.9K
- Earning Date
- XTNT 05-14-2025
- ASRT 05-05-2025
- Dividend Yield
- XTNT N/A
- ASRT N/A
- EPS Growth
- XTNT N/A
- ASRT N/A
- EPS
- XTNT N/A
- ASRT N/A
- Revenue
- XTNT $117,267,000.00
- ASRT $124,961,000.00
- Revenue This Year
- XTNT $15.56
- ASRT N/A
- Revenue Next Year
- XTNT $22.39
- ASRT $11.20
- P/E Ratio
- XTNT N/A
- ASRT N/A
- Revenue Growth
- XTNT 28.44
- ASRT N/A
- 52 Week Low
- XTNT $0.33
- ASRT $0.51
- 52 Week High
- XTNT $0.97
- ASRT $1.80
- Technical
- Relative Strength Index (RSI)
- XTNT 49.25
- ASRT 39.97
- Support Level
- XTNT $0.34
- ASRT $0.57
- Resistance Level
- XTNT $0.43
- ASRT $0.80
- Average True Range (ATR)
- XTNT 0.05
- ASRT 0.05
- MACD
- XTNT 0.01
- ASRT 0.00
- Stochastic Oscillator
- XTNT 68.75
- ASRT 52.50
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.